These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33150879)

  • 1. Combinatorial miRNA-34a replenishment and irinotecan delivery
    Li Y; Jia F; Deng X; Wang X; Lu J; Shao L; Cui X; Pan Z; Wu Y
    Biomater Sci; 2020 Dec; 8(24):7132-7144. PubMed ID: 33150879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging.
    Xie X; Chen Y; Chen Z; Feng Y; Wang J; Li T; Li S; Qin X; Wu C; Zheng C; Zhu J; You F; Liu Y; Yang H
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43865-43878. PubMed ID: 31684723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics.
    Jia F; Li Y; Deng X; Wang X; Cui X; Lu J; Pan Z; Wu Y
    J Nanobiotechnology; 2021 Aug; 19(1):238. PubMed ID: 34380471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan-Loaded Polymeric Micelles as a Promising Alternative to Enhance Antitumor Efficacy in Colorectal Cancer Therapy.
    Campos FL; de Alcântara Lemos J; Oda CMR; de Oliveira Silva J; Fernandes RS; Miranda SEM; Cavalcante CH; Cassali GD; Townsend DM; Leite EA; de Barros ALB
    Polymers (Basel); 2022 Nov; 14(22):. PubMed ID: 36433032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
    Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
    Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer.
    Hosseini M; Baghaei K; Hajivalili M; Zali MR; Ebtekar M; Amani D
    Life Sci; 2022 Feb; 290():120234. PubMed ID: 34953890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxymethyl Dextran-Stabilized Polyethylenimine-Poly(epsilon-caprolactone) Nanoparticles-Mediated Modulation of MicroRNA-34a Expression via Small-Molecule Modulator for Hepatocellular Carcinoma Therapy.
    Deng X; Yin Z; Zhou Z; Wang Y; Zhang F; Hu Q; Yang Y; Lu J; Wu Y; Sheng W; Zeng Y
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17068-79. PubMed ID: 27300477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS-Responsive Polymeric Micelles for Triggered Simultaneous Delivery of PLK1 Inhibitor/miR-34a and Effective Synergistic Therapy in Pancreatic Cancer.
    Xin X; Lin F; Wang Q; Yin L; Mahato RI
    ACS Appl Mater Interfaces; 2019 Apr; 11(16):14647-14659. PubMed ID: 30933478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Responsive PEG-Shedding and Targeting Peptide-Modified Nanoparticles for Dual-Delivery of Irinotecan and microRNA to Enhance Tumor-Specific Therapy.
    Juang V; Chang CH; Wang CS; Wang HE; Lo YL
    Small; 2019 Dec; 15(49):e1903296. PubMed ID: 31709707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy.
    Yao C; Liu J; Wu X; Tai Z; Gao Y; Zhu Q; Li J; Zhang L; Hu C; Gu F; Gao J; Gao S
    J Control Release; 2016 Jun; 232():203-14. PubMed ID: 27126903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer.
    Sadat SMA; Vakili MR; Abd-El Hafeez SI; Paladino M; Hall DG; Weinfeld M; Lavasanifar A
    Mol Pharm; 2024 Jul; 21(7):3240-3255. PubMed ID: 38785196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer.
    Han TY; Hou LS; Li JX; Huan ML; Zhou SY; Zhang BL
    Int J Pharm; 2023 Mar; 635():122755. PubMed ID: 36801480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
    Shi X; Kaller M; Rokavec M; Kirchner T; Horst D; Hermeking H
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):391-418. PubMed ID: 32304779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines.
    Dehghan R; Najafi R; Azizi Jalilian F; Saidijam M; Radaei Z; Zamani A; Ezati R; Asna-Ashari F; Amini R
    Mol Biol Rep; 2021 Jan; 48(1):203-218. PubMed ID: 33398678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
    Lu G; Sun Y; An S; Xin S; Ren X; Zhang D; Wu P; Liao W; Ding Y; Liang L
    Exp Mol Pathol; 2015 Aug; 99(1):173-9. PubMed ID: 26103003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.
    Toden S; Okugawa Y; Buhrmann C; Nattamai D; Anguiano E; Baldwin N; Shakibaei M; Boland CR; Goel A
    Cancer Prev Res (Phila); 2015 May; 8(5):431-43. PubMed ID: 25712055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.